Almanack Investment Partners, Llc. Bristol Myers Squibb CO Transaction History
Almanack Investment Partners, Llc.
- $570 Million
- Q1 2024
A detailed history of Almanack Investment Partners, Llc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Almanack Investment Partners, Llc. holds 6,004 shares of BMY stock, worth $245,323. This represents 0.06% of its overall portfolio holdings.
Number of Shares
6,004
Previous 5,733
4.73%
Holding current value
$245,323
Previous $294,000
10.54%
% of portfolio
0.06%
Previous 0.04%
Shares
10 transactions
Others Institutions Holding BMY
# of Institutions
2,555Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.6 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.64 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.74 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.63 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.87 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $86.9B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...